Hypertrophic and Keloid Scar Treatment Market Size, Share And Growth Analysis For 2024-2033

August 15, 2024 12:45 AM AEST | By EIN Presswire
 Hypertrophic and Keloid Scar Treatment Market Size, Share And Growth Analysis For 2024-2033
Image source: EIN Presswire

LONDON, GREATER LONDON, UK, August 14, 2024 /EINPresswire.com/ -- The hypertrophic and keloid scar treatment market has shown robust growth, expanding from $6.91 billion in 2023 to $7.67 billion in 2024, with a compound annual growth rate (CAGR) of 11.0%. This growth is driven by an increase in the incidence of hypertrophic and keloid scars, advancements in scar assessment, and the widespread adoption of topical treatments and surgical procedures. The market is projected to reach $11.14 billion by 2028, at a CAGR of 9.8%, reflecting a continued strong demand for effective scar treatments.

Rising Aesthetic Procedures Fuel Market Growth
The rise in aesthetic procedures is a key driver for the hypertrophic and keloid scar treatment market. Aesthetic procedures, including non-invasive and minimally invasive cosmetic treatments, address cosmetic concerns and enhance appearance. For instance, a 54% increase in US plastic surgical procedures in 2021, as reported by the Aesthetic Society, highlights the growing demand for aesthetic treatments. These procedures contribute to smoother and more aesthetically pleasing outcomes for scar management, propelling market growth.

Explore comprehensive insights into the hypertrophic and keloid scar treatment market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=10692&type=smp

Key Players and Technological Innovations
Prominent companies in the hypertrophic and keloid scar treatment market include Smith & Nephew PLC, Merz Pharmaceutical LLC, Lumenis Ltd., and Cynosure Inc. These companies are focusing on advanced dermatological solutions, such as Microcyn technology, to enhance scar treatment efficacy. For example, Sonoma Pharmaceuticals launched products like Regenacyn Plus and Reliefacyn Plus in January 2023, which leverage Microcyn technology to improve the appearance of scars, provide relief, and reduce infection risks.

Major Trends Shaping the Market
Emerging trends in the hypertrophic and keloid scar treatment market include injectable therapies, combination therapies for synergistic effects, patient-centric approaches, and advancements in scar assessment technologies. The rise of telemedicine for consultations and follow-up is also noteworthy. These trends reflect the industry's commitment to innovative and effective scar treatment solutions.

Market Segmentation
• By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments
• By Products: Topical Products, Laser Products, Injectables, Other Products
• By Scar: Hypertrophic Scars, Keloid Scars
• By End-Use: Hospitals, Clinics, Other End-Users

Geographical Insights: North America Leading the Market
North America was the largest region in the hypertrophic and keloid scar treatment market in 2023. However, Asia-Pacific is anticipated to be the fastest-growing region during the forecast period, driven by increasing healthcare access and rising aesthetic procedures in the region.

Explore the report store to make a direct purchase of the report
https://www.thebusinessresearchcompany.com/report/hypertrophic-and-keloid-scar-treatment-global-market-report

Hypertrophic And Keloid Scar Treatment Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Hypertrophic And Keloid Scar Treatment Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on hypertrophic and keloid scar treatment market size, hypertrophic and keloid scar treatment market drivers and trends, hypertrophic and keloid scar treatment market major players, competitors' revenues, market positioning, and market growth across geographies. The hypertrophic and keloid scar treatment market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Hypodermic Syringes And Needles Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hypodermic-syringes-and-needles-global-market-report

Hysteroscopy Procedures Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hysteroscopy-procedures-global-market-report

Hyperpigmentation Disorder Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hyperpigmentation-disorder-treatment-global-market-report

About The Business Research Company?
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.